BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26358398)

  • 21. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
    Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
    Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
    Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
    Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infectious Bursal Disease Virus Activates c-Src To Promote α4β1 Integrin-Dependent Viral Entry by Modulating the Downstream Akt-RhoA GTPase-Actin Rearrangement Cascade.
    Ye C; Han X; Yu Z; Zhang E; Wang L; Liu H
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrin stimulates pancreatic cancer cell directional migration by activating the Gα12/13-RhoA-ROCK signaling pathway.
    Mu G; Ding Q; Li H; Zhang L; Zhang L; He K; Wu L; Deng Y; Yang D; Wu L; Xu M; Zhou J; Yu H
    Exp Mol Med; 2018 May; 50(5):1-14. PubMed ID: 29717112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin.
    Zheng S; Huang J; Zhou K; Zhang C; Xiang Q; Tan Z; Wang T; Fu X
    PLoS One; 2011; 6(7):e22439. PubMed ID: 21818323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.
    Struckhoff AP; Rana MK; Kher SS; Burow ME; Hagan JL; Del Valle L; Worthylake RA
    J Cell Sci; 2013 Oct; 126(Pt 19):4514-26. PubMed ID: 23868972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.
    Korourian A; Roudi R; Shariftabrizi A; Madjd Z
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1842-1847. PubMed ID: 28836853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells.
    Kolb K; Hellinger J; Kansy M; Wegwitz F; Bauerschmitz G; Emons G; Gründker C
    Cells; 2020 Dec; 9(12):. PubMed ID: 33291460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer.
    Murray D; Horgan G; Macmathuna P; Doran P
    Br J Cancer; 2008 Oct; 99(8):1322-9. PubMed ID: 18827818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FKBP51 regulates cell motility and invasion via RhoA signaling.
    Takaoka M; Ito S; Miki Y; Nakanishi A
    Cancer Sci; 2017 Mar; 108(3):380-389. PubMed ID: 28032931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paeoniflorin Inhibits Hepatocyte Growth Factor- (HGF-) Induced Migration and Invasion and Actin Rearrangement via Suppression of c-Met-Mediated RhoA/ROCK Signaling in Glioblastoma.
    Yu G; Wang Z; Zeng S; Liu S; Zhu C; Xu R; Liu RE
    Biomed Res Int; 2019; 2019():9053295. PubMed ID: 30886866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-κB-dependent MMP-9 expression via ROS.
    Huang L; Lin H; Chen Q; Yu L; Bai D
    BMC Cancer; 2019 Nov; 19(1):1159. PubMed ID: 31783821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion.
    Hanna S; Khalil B; Nasrallah A; Saykali BA; Sobh R; Nasser S; El-Sibai M
    Int J Oncol; 2014 May; 44(5):1499-511. PubMed ID: 24627003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SHROOM2 inhibits tumor metastasis through RhoA-ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma.
    Yuan J; Chen L; Xiao J; Qi XK; Zhang J; Li X; Wang Z; Lian YF; Xiang T; Zhang Y; Chen MY; Bei JX; Zeng YX; Feng L
    Cell Death Dis; 2019 Jan; 10(2):58. PubMed ID: 30683844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion.
    Ye Y; Tang X; Sun Z; Chen S
    Oncotarget; 2016 Apr; 7(14):17854-69. PubMed ID: 26895380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of focal adhesion kinase activation, breast cancer cell motility, and amoeboid invasion by the RhoA guanine nucleotide exchange factor Net1.
    Carr HS; Zuo Y; Oh W; Frost JA
    Mol Cell Biol; 2013 Jul; 33(14):2773-86. PubMed ID: 23689132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis.
    Deakin NO; Turner CE
    Mol Biol Cell; 2011 Feb; 22(3):327-41. PubMed ID: 21148292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.